From biosimilars to process intensification: 5 key trends in the biopharma space today

By Jane Byrne contact

- Last updated on GMT

Related tags: cell and gene therapy, Biosimilars

Related news

Show more

Related products

show more

Manufacturing of hiPSC-Derived Cardiomyocytes

Manufacturing of hiPSC-Derived Cardiomyocytes

Eppendorf for Bioprocess – Solutions that grow with you | 29-Oct-2020 | Application Note

Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent...

Follow us

Products

View more

Webinars